a, Mitochondrial swelling induced by 500 μM
Ca2+ (n = 4 per group).
b, Mitochondrial swelling normalized before
Ca2+ addition (n =4 per group).
c, Mitochondrial shrinkage induced by PEG (n
= 4 per group). d, Per cent change in swelling versus
control. e, Images of dihydroethidium (DHE) staining in live left
ventricular tissue. Scale bars, 40 μm; n =10
Slc8b1fl/fl, n =8
MCM, n =19 Slc8b1fl/fl
×MCM. f, Fold-change in DHE signal versus control.
g, Evans blue dye (EBD) and wheat germ agglutinin (WGA)
staining in left ventricular tissue 3 days post tamoxifen. Scale bars, 50
μm. h, Per cent EBD+ cardiomyocytes.
n = 15 mice per group. i,
Kaplan–Meier survival curves of mice during tamoxifen treatment.
n =7
Ppif−/−, 10 MCM, 8
Slc8b1fl/fl ×MCM, 8
Slc8b1fl/fl ×MCM
×Ppif−/−.
j, Per cent fractional shortening (FS) 3 days post tamoxifen
administration. n = 5–6 mice per group.
k, Heart weight to body weight ratio 3 days post tamoxifen
treatment. n = 5 mice per group. l,
Electron microscopy images of left ventricular tissue 3 days after tamoxifen
treatment, imaged at 5,000× magnification (scale bars, 1 μm) and
16,000× magnification (scale bars, 500 nm). m,
Mitochondrial cristae density, represented as per cent area void of cristae.
n = 3–4 mice per group. n,
Mitycam mCa2+ transients of ACMs paced at 0.1 Hz.
F/F0 indicates the maximum fluorescence of the
cell over the average fluorescence before stimulation. o,
mCa2+ peak amplitude. p,
mCa2+ time to 25% decay.
n =7 Cre, n
=14 Slc8b1fl/fl ×Cre ACMs.
q–s, mCa2+
uptake and efflux in isolated, permeabilized ACMs. dig., digitonin; thaps.,
thapsigargin; Ru360, MCU inhibitor; CGP, NCLX inhibitor. Inset, magnified
smoothed efflux tracing. R indicates the ratio of the
ratiometric reporter Fura-FF (340/380 nm excitation and 510 nm emission).
R/R0 indicates the ratio at each time point over
the ratio at time 0. t, Wild-type ACMs pre-treated with NCLX
inhibitor. u, mCa2+ efflux rate.
n = 3 replicates per group;
*P <0.05, **P
<0.01, ***P <0.001.